Profile data is unavailable for this security.
About the company
Hunan FangshengPharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of cardiovascular medicine, orthopedic medicine, pediatric medicine, gynecological medicine and anti-infective medicine. The Company's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The Company distributes its products primarily in domestic market.
- Revenue in CNY (TTM)1.63bn
- Net income in CNY193.23m
- Incorporated1997
- Employees1.69k
- LocationHunan Fangsheng Pharmaceutical Co LtdNo.19 Lutian Road, Lugu, HexiCHANGSHA 410205ChinaCHN
- Phone+86 73 188997135
- Fax+86 73 188908647
- Websitehttp://www.fangsheng.com.cn
More ▼
Mergers & acquisitions
Acquired company | 603998:SHH since announced | Transaction value |
---|---|---|
Hunan Fangsheng Ruixin Pharmaceutical Co Ltd | 17.69% | 2.26m |
Data delayed at least 15 minutes, as of May 31 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 4.91bn | 295.00 | 111.66 | 3.93 | -- | 20.49 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
InventisBio Co Ltd | 194.13m | -249.28m | 5.02bn | 221.00 | -- | 2.60 | -- | 25.87 | -0.4289 | -0.4289 | 0.3348 | 3.35 | 0.0898 | -- | 1.96 | 878,429.50 | -11.53 | -- | -12.26 | -- | 97.85 | -- | -128.41 | -- | -- | -- | 0.0054 | -- | -- | -- | 41.26 | -- | -- | -- |
HitGen Inc | 409.13m | 64.05m | 5.06bn | 452.00 | 78.94 | 3.68 | -- | 12.38 | 0.1601 | 0.1601 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
Hunan Fangsheng Pharmaceutical Co Ltd | 1.63bn | 193.23m | 5.20bn | 1.69k | 26.74 | 3.39 | -- | 3.19 | 0.4428 | 0.4428 | 3.72 | 3.49 | 0.5227 | 1.48 | 6.56 | 966,866.90 | 5.93 | 5.39 | 9.72 | 9.37 | 67.75 | 66.91 | 11.34 | 8.95 | 0.5527 | 16.41 | 0.3447 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 799.09m | 269.00m | 5.45bn | 1.14k | 19.64 | 2.35 | -- | 6.82 | 1.37 | 1.37 | 4.08 | 11.49 | 0.2573 | 0.9016 | 6.83 | 699,118.90 | 8.66 | 10.04 | 10.48 | 11.63 | 81.31 | 83.66 | 33.66 | 28.29 | 3.33 | -- | 0.2547 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 5.49bn | 404.00 | 20.63 | 2.76 | -- | 8.78 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
Shanghai Yizhong Pharmaceutical Co Ltd | 336.56m | 135.71m | 5.53bn | 43.00 | 40.76 | 3.69 | -- | 16.45 | 0.66 | 0.66 | 1.64 | 7.28 | 0.2219 | 0.9416 | 3.28 | 7,826,913.00 | 8.95 | -0.9181 | 9.39 | -0.9485 | 93.54 | 93.19 | 40.32 | -6.11 | 12.66 | -- | 0.0342 | -- | 52.68 | -- | 13.09 | -- | 20.44 | -- |
Beijing Sun-Novo Pharma Research Co Ltd | 951.95m | 209.57m | 5.55bn | 1.37k | 26.46 | 5.47 | -- | 5.83 | 1.87 | 1.87 | 8.50 | 9.06 | 0.5465 | 26.19 | 1.77 | 694,854.30 | 11.70 | 12.99 | 19.13 | 21.70 | 59.10 | 53.93 | 21.40 | 21.34 | 1.77 | 45.00 | 0.3721 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
Data as of May 31 2024. Currency figures normalised to Hunan Fangsheng Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
E Fund Management Co., Ltd.as of 31 Dec 2023 | 39.49m | 9.29% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 9.51m | 2.24% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.11m | 1.91% |
Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 7.73m | 1.82% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 4.71m | 1.11% |
Hotland Innovation Asset Management Co. Ltd.as of 31 Dec 2023 | 3.81m | 0.90% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 2.73m | 0.64% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.82m | 0.43% |
CIB Fund Management Co., Ltd.as of 31 Dec 2023 | 1.67m | 0.39% |
Hui'an Fund Management Co. Ltd.as of 31 Dec 2023 | 1.58m | 0.37% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.